Literature DB >> 2969062

Cell-mediated cytotoxic activity of spleen cells from patients with gastric carcinoma.

T Akiyoshi1, F Koba, S Arinaga, T Wada, H Tsuji.   

Abstract

The cell-mediated cytotoxic activities of cells from the spleens (SP cells) of patients with gastric carcinoma were assayed in comparison with the activities of peripheral blood mononuclear cells (PBM cells) from the same patients, and from patients with benign lesions. The natural killer cell (NK) activity of the SP cells and their capacity to generate allogeneic cytotoxicity in mixed lymphocyte culture (MLC) were very similar to those of the PBM cells. The cytotoxic activity of SP cells induced by alloactivation in MLC, however, was significantly higher than that of the PBM cells from the same patient as well as from patients with benign lesions. The production of interleukin 2 (IL 2) and the ability to induce cytotoxic cells after activation with IL 2 (LAK) were therefore examined. Both the ability to produce IL 2 and to generate LAK cells were shown to be significantly increased in SP cells when compared to PBM cells. These results indicate that the spleen may be a potential reservoir for the precursors of these activated killer cells in patients with gastric carcinoma. Furthermore, it may play an important role in the defence against tumors in these patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2969062     DOI: 10.1007/bf02471426

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  25 in total

1.  Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.

Authors:  K M Matchett; A T Huang; W B Kremer
Journal:  J Clin Invest       Date:  1973-08       Impact factor: 14.808

2.  Separation of functional subsets of human T cells by a monoclonal antibody.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

3.  Natural killer activity in spleens and lymph nodes from patients with Hodgkin's disease.

Authors:  L P Ruco; A Procopio; S Uccini; E Marcorelli; C D Baroni
Journal:  Cancer Res       Date:  1982-05       Impact factor: 12.701

4.  Suppression of the mixed lymphocyte reaction by alloantigen-primed and -stimulated human spleen lymphocytes.

Authors:  A N Akbar; D B Jones
Journal:  Immunology       Date:  1984-02       Impact factor: 7.397

5.  Tissue T-lymphocytes in untreated Hodgkin's disease: morphologic and functional correlations in spleens and lymph nodes.

Authors:  C D Baroni; L Ruco; S Uccini; A Foschi; M Occhionero; E Marcorelli
Journal:  Cancer       Date:  1982-07-15       Impact factor: 6.860

6.  The human splenic suppressor cell.

Authors:  D Sampson; C Grotelueschen; H M Kauffman
Journal:  Transplantation       Date:  1975-11       Impact factor: 4.939

7.  Lysis of fresh human solid tumor cells by autologous lymphocytes activated in vitro by allosensitization.

Authors:  A Mazumder; E A Grimm; S A Rosenberg
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

8.  Characterization of the lysis of fresh human solid tumors by autologous lymphocytes activated in vitro with phytohemagglutinin.

Authors:  A Mazumder; E A Grimm; S A Rosenberg
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

9.  Concanavalin A-induced and spontaneous suppressor cell activities in peripheral blood lymphocytes and spleen cells from gastric cancer patients.

Authors:  T Toge; S Hamamoto; E Itagaki; K Yajima; M Tanada; H Nakane; H Kohno; K Nakanishi; T Hattori
Journal:  Cancer       Date:  1983-11-01       Impact factor: 6.860

10.  Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells.

Authors:  E A Grimm; K M Ramsey; A Mazumder; D J Wilson; J Y Djeu; S A Rosenberg
Journal:  J Exp Med       Date:  1983-03-01       Impact factor: 14.307

View more
  1 in total

Review 1.  [Role of the spleen in tumor surgery].

Authors:  U Wolters; H W Keller; H Pichlmaier
Journal:  Langenbecks Arch Chir       Date:  1991
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.